ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver.
Christian David SchmidVictor OlsavszkyManuel ReinhartVanessa WeyerFelix A TrogischCarsten StichtManuel WinklerSina W KürschnerJohannes HoffmannRoxana OlaTheresa StaniczekJoerg HeinekeBeate K StraubJens MittlerKai SchledzewskiPeter Ten DijkeKarsten RichterSteven DooleyCyrill GéraudSergij GoerdtPhilipp-Sebastian KochPublished in: Hepatology (Baltimore, Md.) (2022)
HHT model offers opportunities to develop targeted therapies for this severe disease.